219 related articles for article (PubMed ID: 28719837)
1. Prescription trends and the selection of initial oral antidiabetic agents for patients with newly diagnosed type 2 diabetes: a nationwide study.
Liu CH; Chen ST; Chang CH; Chuang LM; Lai MS
Public Health; 2017 Nov; 152():20-27. PubMed ID: 28719837
[TBL] [Abstract][Full Text] [Related]
2. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
3. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study.
Chang YC; Chuang LM; Lin JW; Chen ST; Lai MS; Chang CH
Diabet Med; 2015 Nov; 32(11):1460-9. PubMed ID: 25970814
[TBL] [Abstract][Full Text] [Related]
5. The prescription pattern of initial treatment for type 2 diabetes in Beijing from 2011 to 2015.
Wang X; Cao Y; Wu Y; Yang C; Song J; Tian Y; Wang M; Li M; Wu Y; Hu Y
Medicine (Baltimore); 2019 Feb; 98(8):e14370. PubMed ID: 30813137
[TBL] [Abstract][Full Text] [Related]
6. Use of antidiabetic drugs in the U.S., 2003-2012.
Hampp C; Borders-Hemphill V; Moeny DG; Wysowski DK
Diabetes Care; 2014; 37(5):1367-74. PubMed ID: 24623020
[TBL] [Abstract][Full Text] [Related]
7. Trends in antidiabetic medical treatment from 2005 to 2014 in Taiwan.
Chu CH; Hsu CC; Lin SY; Chuang LM; Liu JS; Tu ST
J Formos Med Assoc; 2019 Nov; 118 Suppl 2():S74-S82. PubMed ID: 31248659
[TBL] [Abstract][Full Text] [Related]
8. Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study.
Ko SH; Kim DJ; Park JH; Park CY; Jung CH; Kwon HS; Park JY; Song KH; Han K; Lee KU; Ko KS;
Medicine (Baltimore); 2016 Jul; 95(27):e4018. PubMed ID: 27399082
[TBL] [Abstract][Full Text] [Related]
9. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
Aquilante CL; Zhang W; McCollum M
Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
[TBL] [Abstract][Full Text] [Related]
10. Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001.
Wysowski DK; Armstrong G; Governale L
Diabetes Care; 2003 Jun; 26(6):1852-5. PubMed ID: 12766122
[TBL] [Abstract][Full Text] [Related]
11. [Antidiabetic drugs prescription patterns among a group of patients in Colombia].
Machado Alba JE; Moncada Escobar JC; Mesa Escobar G
Rev Panam Salud Publica; 2007 Aug; 22(2):124-31. PubMed ID: 17976279
[TBL] [Abstract][Full Text] [Related]
12. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
[TBL] [Abstract][Full Text] [Related]
13. Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013.
Clemens KK; Liu K; Shariff S; Schernthaner G; Tangri N; Garg AX
Diabetes Obes Metab; 2016 Jun; 18(6):607-14. PubMed ID: 26939711
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk associated with acarbose versus metformin as the first-line treatment in patients with type 2 diabetes: a nationwide cohort study.
Chang CH; Chang YC; Lin JW; Chen ST; Chuang LM; Lai MS
J Clin Endocrinol Metab; 2015 Mar; 100(3):1121-9. PubMed ID: 25555040
[TBL] [Abstract][Full Text] [Related]
15. Keeping up with guideline recommendations: does patient volume matter in diabetes care?
Chen YC; Cheng SH; Chen CC
Am J Manag Care; 2020 Aug; 26(8):e264-e271. PubMed ID: 32835469
[TBL] [Abstract][Full Text] [Related]
16. The impact of initial antidiabetic agent and use of monitoring agents on prescription costs in newly treated type 2 diabetes: A retrospective cohort analysis.
Grimes RT; Bennett K; Canavan R; Tilson L; Henman MC
Diabetes Res Clin Pract; 2016 Mar; 113():152-9. PubMed ID: 26810270
[TBL] [Abstract][Full Text] [Related]
17. Initial Therapeutic Choices for Type 2 Diabetes in the Portuguese Sentinel Practice Network.
Pinto D; Rodrigues AP; Nunes B
Acta Med Port; 2019 May; 32(5):375-380. PubMed ID: 31166898
[TBL] [Abstract][Full Text] [Related]
18. Effects of early medication treatment and metformin use for cancer prevention in diabetes patients: a nationwide sample cohort study in Korea using extended landmark time analysis.
Seo HJ; Oh HS
Epidemiol Health; 2021; 43():e2021103. PubMed ID: 34922421
[TBL] [Abstract][Full Text] [Related]
19. Trends in the prescription of antidiabetic medications in France: evidence from primary care physicians.
Boyc KS; Yurgin N; Lage MJ
Adv Ther; 2007; 24(4):803-13. PubMed ID: 17901029
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
Koro CE; Bowlin SJ; Weiss SR
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):697-703. PubMed ID: 15654719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]